Language

Afalaza 6 mg + 6 mg — packaging
Packaging may differ

Afalaza 6 mg + 6 mg prices in Yerevan pharmacies

affinity purified antibodies to endothelial NO synthase, affinity purified antibodies to prostate-specific antigen · tablets · 6 mg + 6 mg · over the counter

NPF Materia Medica Holding LLC · Russia

Registration No. 19749

  • Over the counter

Prices at 2 online pharmacies

100 pcs · by pack price · prices from pharmacy websites as of 15 Oct 2026

in stock · out of stock · no mark — the pharmacy does not report stock⁠About these prices

These are prices of the pharmacy chains' online shops, not of a particular branch. The list is sorted by pack price; pharmacies where the medicine is out of stock come last.

“≈ … per unit” is Medaro’s calculation: the pack price divided by the number of units (for liquids and ointments — per 10 ml or 10 g), rounded.

Medaro does not sell medicines and is not paid by pharmacies for their place in the list.

Medaro does not sell medicines and is not paid by pharmacies for their place in the list.

Product record

Trade name
Afalaza
Active ingredient (INN)
affinity purified antibodies to endothelial NO synthase, affinity purified antibodies to prostate-specific antigen
ATC code
G04C
Registration certificate
No. 19749
Dispensing
Over the counter

The register has no link to the official leaflet yet — read the leaflet in the pack.

State Register of Medicines (pharm.am) (opens in a new tab)
Show all detailsHide details
Dosage form
tablets
Strength
6 mg + 6 mg
Marketing authorisation holder
NPF Materia Medica Holding LLC, 9 bld., 3rd Samotyochny per., Moscow 127473, Russia
Manufacturer
NPF Materia Medica Holding LLC, 54, Buguruslanskaya st., Chelyabinsk 454139
Country
Russia

Details from the State Register of Medicines of Armenia as of 31 Aug 2026. No indications, directions for use or dosing regimen here — read the official leaflet.

Spotted an error? Let us know

As a rule, we will send you a confirmation that your message has been received and, once the check is done, its outcome. We need your address only for emails about this message: it is not published on the site and is not added to any mailing list. Privacy policy